Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2015

Apr 20, 2015

5262_dirs_2015-04-20_c401571e-7fc4-44d2-8211-bc9f8d0695ce.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7246K

GlaxoSmithKline PLC

20 April 2015

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline US Deferred Performance Share Plan (the Plan) notified the Company and the under-mentioned Director and Person Discharging Managerial Responsibilities (PDMR) on 17 April 2015 of the following increase in interests in American Depositary Shares (ADSs) at a price of $47.72 per ADS following the re-investment of the dividend paid to shareholders on 9 April 2015.

Director/PDMR ADSs
Dr M M Slaoui 297.838
Mr D E Troy 400.708

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

20 April 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSLBLFLEZFEBBQ